AZNCF - AstraZeneca's (AZN) CEO Pascal Soriot on Q3 2020 Results - Earnings Call Transcript

AstraZeneca PLC (AZN) Q3 2020 Earnings Conference Call November 05, 2020 6:45 AM ET Company Participants Pascal Soriot – Chief Executive Officer Dave Fredrickson – Executive Vice President of the Oncology Business Unit Ruud Dobber – Executive Vice President of the Biopharmaceuticals Business Unit Marc Dunoyer – Executive Director and Chief Financial Officer Mene Pangalos – Executive Vice President of the Biopharmaceuticals R&D Group Jose Baselga – Executive Vice President of Oncology R&D Pam Cheng – Executive Vice President of Operations and IT Leon Wang – Executive Vice President for the China and Emerging Markets Conference Call Participants Andrew Baum – Citi Luisa Hector – Berenberg Richard Parkes – Exane Steve Scala – Cowen Sachin Jain – Bank of America Keyur Parekh – Goldman Mark Purcell – Morgan Stanley Tim Anderson – Wolfe Research Seamus Fernandez – Guggenheim Matt Weston – Credit Suisse James Gordon – JP Morgan Peter Welford

For further details see:

AstraZeneca's (AZN) CEO Pascal Soriot on Q3 2020 Results - Earnings Call Transcript